Our scientists are examining the potential of natural and novel synthetic cannabinoids for targeted cancer treatment.
In partnership with the National Cancer Institute of Lithuania, our scientific team is researching the potential of natural and novel synthetic cannabinoids for targeted cancer treatment based on their molecular mechanisms.
The vast chemical space available through stereoselective synthesis using previously unexplored starting materials and reaction sequences holds a promise of a substantial breakthrough in identifying new therapeutic agents.
Starting with in vitro experiments, scientists are investigating the bioactivity of a broad range of different cannabinoids, identifying the most promising ones and conducting their further evaluation. The National Cancer Institute is conducting molecular studies of anti-cancer effects of cannabinoids in contemporary 3D cell cultures and in vivo models.